Adamis Pharmaceuticals Corporation (ADMP) Stock Overview
Explore Adamis Pharmaceuticals Corporation’s financial performance, market position, analyst ratings, and future outlook.
Adamis Pharmaceuticals Corporation (ADMP)
Key Financials
Key Financials
Market Cap
7.3M
P/E Ratio
-0.06
EPS (TTM)
$-10.14
ROE
-2.09%
ADMP Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Adamis Pharmaceuticals Corporation (ADMP) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.00.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.06 and a market capitalization of 7.3M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.